Delivery Order SPE2DB20D7061-SPE2DB25FSPA2
- Not listed
- The Defense Logistics Agency awarded a $14,651.28 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gamunex-C 10 gram/100 mL vials (100 mL quantity). This is a firm fixed-price, non-set-aside contract with a completion date of October 8, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,036.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials. The contract is set to be completed by September 10, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials valued at $3,644.04 with a completion date of October 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials with a ceiling value of $1,214.68. This is a firm fixed-price delivery order without set-aside designation, with an ultimate completion date of September 15, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $28,323.36 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 20 gram/200 mL vials on July 22, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a competitive award with no set-aside designation. The contractor will perform from its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded a $15,311.23 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials with an ultimate completion date of June 11, 2025. This firm fixed-price delivery order represents a non-set-aside award, reflecting open competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,651.54 under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Gamunex-C 10 gram/100 mL vials valued at $18,314.10 with a firm fixed price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,981.60 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin vial. The contract, issued on August 6, 2025, carries a firm fixed price and is scheduled for completion by August 27, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPA2Delivery Order
The Defense Logistics Agency awarded a $3,540.39 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Gamunex-C 20 gram/200 milliliter vials. The contract is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement, indicating it was awarded through competitive procedures. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle valued through December 2026 that serves as a comprehensive pharmaceutical support mechanism for military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and Defense Health Agency. The company's Indefinite Delivery Contract encompasses a broad range of pharmaceutical products and medical supplies including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular delivery order for Gamunex-C, an immunoglobulin replacement therapy product, reflects the contractor's ongoing role as a critical vendor supporting federal medical procurement needs for military and veteran healthcare systems. The DLA Troop Support is planning successor Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving as a key healthcare commodity supplier.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 7/24/25 |